scispace - formally typeset
Q

Qian Zhang

Researcher at Reuben H. Fleet Science Center

Publications -  51
Citations -  2126

Qian Zhang is an academic researcher from Reuben H. Fleet Science Center. The author has contributed to research in topics: Oncolytic virus & Virus. The author has an hindex of 24, co-authored 43 publications receiving 1956 citations. Previous affiliations of Qian Zhang include University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins

TL;DR: Findings indicate that neither auxotrophic mutations, nor vaccinia virus deficient for the thymidine kinase gene, nor anaerobic growth conditions were required for tumor specificity and intratumoral replication.
Journal ArticleDOI

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

TL;DR: It is suggested that immune activation may combine with viral oncolysis to induce tumor eradication in this model, providing a novel perspective for the design of on colytic viral therapies for human cancers.
Journal ArticleDOI

Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer.

TL;DR: Evidence is provided that gene-evoked production of melanin can be used as a therapeutic and diagnostic mediator as exemplified by insertion of only one or two genes into the genome of an oncolytic vaccinia virus strain, and produced melanin is an excellent reporter for optical imaging without addition of substrate.
Journal ArticleDOI

Regression of human pancreatic tumor xenografts in mice after a single systemic injection of recombinant vaccinia virus GLV-1h68

TL;DR: The GLV-1h68 strain showed outstanding therapeutic effects and a documented safety profile in mice, with great promise for future clinical development.
Journal ArticleDOI

Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy

TL;DR: The construction of 3 VACV strains encoding GLAF-1, a previously undescribed engineered single-chain antibody (scAb), which exhibited significantly enhanced therapeutic efficacy in comparison to treatment of human tumor xenografts with the parental virus GLV-1h68.